Hims & Hers hit with securities class action
Alpha Vantage · GlobeNewswire · · AI-summarised by FinFlash
Bronstein, Gewirtz & Grossman LLC has filed a class action against Hims & Hers Health (NYSE: HIMS) and certain officers, alleging violations of federal securities laws. The suit claims the company made false and misleading statements, including sharing consumer health information with third-party advertisers and charging for prescriptions before medical consultations. Investors who bought Hims securities between August 4, 2025 and July 29, 2026 may seek lead plaintiff status by November 1, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.